chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This patient contacted the Vaccine Healthcare Center on 14 December 2005 complaining of soreness in his left shoulder blade with tingling from left midaxillary line 5th ICS up to axilla radiating down under arm to entire palm of left hand. Occurred initally once every 2 days for 30 secs and now has progressed to 30-60 sec every 4 hours. Denies any weakness, grip problems, chest pain, palpitations, SOB, radiating pain or discomfort, n/v/d, neck pain, jaw pain or any discomfort, or any visible rash. Advised to follow up with ER or PCP for evaluation of atypical myopercarditis vs musculoskeletal causes vs shingles. He called back later to state he was fine and released from the ER unknown diagnosis. No further contact has been made by this service member and medical records remain pending as of May 2006.  Review of CHCS II noted a CXR on 14 Dec 2005 as normal.  A c-spine film for complaints of right arm pain from the posterior shoulder area radiating down the lateral/posterior aspect to his fingers for 2 weeks was ordered on 18 Apr 2006. He had no paresthesia or other symptoms.  Strength was 5/5 equal bilaterally.  The x-ray showed "lordosis is reversed with arthritic changes to verterbral bodies of C4-5-6 with anterior and posterior marginal osteophytes present.  There is disc thinning and decreased vertebral height at C5 and C6." With this update the original symptoms of left arm tingling may be related to arthritic and disc changes from C4-6.  There have been no report of any cardiac symptoms at this time.
Adverse events; Circle around injection site; Redness; Swelling (L); Hard around injection site; Fatigue; Pain at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Redness), SWELLING (Swelling (L)), VACCINATION SITE REACTION (Circle around injection site), VACCINATION COMPLICATION (Adverse events) and VACCINATION SITE INDURATION (Hard around injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included VITAMINS NOS for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site). On 23-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hard around injection site). On 25-Jan-2021, the patient experienced ERYTHEMA (Redness) and SWELLING (Swelling (L)). On 28-Jan-2021, the patient experienced VACCINATION SITE REACTION (Circle around injection site). On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse events). On 24-Jan-2021, VACCINATION SITE PAIN (Pain at injection site) had resolved. On 25-Jan-2021, VACCINATION SITE INDURATION (Hard around injection site) and FATIGUE (Fatigue) had resolved. On 28-Jan-2021, ERYTHEMA (Redness) and SWELLING (Swelling (L)) had resolved. On 01-Feb-2021, VACCINATION SITE REACTION (Circle around injection site) had resolved. At the time of the report, VACCINATION COMPLICATION (Adverse events) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included acetaminophen, diphenhydramine and ice.
COVID arm (delayed by a few days) with first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm (delayed by a few days) with first shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hives. Family history included Skin reaction (hives, etc.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm (delayed by a few days) with first shot). At the time of the report, VACCINATION SITE REACTION (COVID arm (delayed by a few days) with first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided by the reporter. No Treatment information was reported.   This case was linked to MOD-2021-395795 (Patient Link).
Approximately 15 minutes after the vaccination the patient reported dizziness and possible rash on her upper chest. It was difficult to assess if the rash was truly a rash or it was simply skin lesions that were already present (patient claimed she did not know). It did not resemble a maculopapular rash. It marginally resembled minor hives/urticaria. Patient did not report any localized symptoms at injection site. Patient was informed to remain seated and that her vitals would be taken and she would be further observed. Then about 10 minutes after this (25 minutes after vaccination), patient reported difficulty breathing. Facial redness was noted at this point and patient's breathing sounded difficult. Emergency medical services were called and EpiPen was administered at this point. Patient began to tremble and pace of breathing increased. Emergency medical technicians arrived, took vitals / EKG, and assessed the patient. EMT assessment did not reveal urticaria. EMT instructed patient to control her breathing. The EMTs believe that it may not have been a true reaction but rather the patient may have been suffering from an anxiety attack. Patient was then taken to local ER for further evaluation.
That evening had a fever and fatigue that caused him to feel extremely ill. Continued until the next day.
redness, heat, itching from shoulder to elbow front & sides of lt arm x 3 days;no when seen on 11/2/99;
I began to exhibit flu like symptoms with body aches and a feverish feeling. It eventually developed to a temperature of 99.4 on day 4. I had mild chills, and I was tired. A day or 2 later I was coughing up green phlegm, so I made a Teladoc appointment. I advised that I was an asthmatic and that typically the doctor places me on antibiotics and steroids. The doctor said that she believed the fever was related to the vaccine but not the green sputum. I was negative for COVID-2 when I completed the home test on yesterday. I was given a 5-day Z-PAK of azithromycin and 5 days of prednisone. The flu like symptoms is improving. I do not know if I have completed recovered from the symptoms.
Vaccine dose given on 9/3/21. Noticed an itchy rash on back and abdomen when i woke up 9/5/21. on 9/6/21 i then noticed it spread to the rest of my body. It did not get any better after a week and was only spreading more. Went to the doctor  on 9/10/21 and was prescribed medicine to treat the rash.
Intense pain, swelling, and tenderness in my right hand pinky finger the next day. Throbbing sensation as well. Went a 4 days later to the doctor and was told I have gout as a 22 year old female with an active lifestyle and healthy eating habits. Was given a steroid shot and the prescribed antibiotics and steroids to take. Took them as recommended and 7 days later I still have swelling and tenderness in my pinky.
The client was diagnosed with COVID-19 and was full-vaccinated.  He was hospitalized from what appears to be September 24-25, 2021.  He had co-morbid conditions (Myeloma, Kidney Failure, Diabetes, Dialysis) and passed away on September 28, 2021.
This report is regarding the Pfizer COVID-19 vaccination you received on the above date, which was lot number FD0809. The Public Health District, per guidance from the Department of Health (ODH), Centers for Disease Control and Preventio (CDC), and Pfizer have determined that the dose of vaccine that you received is valid.
soreness at injection site; feels hot; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 45-year-old female patient who received HBV (Engerix B adult) for prophylaxis.   Concurrent medical conditions included food allergy.   On 22nd April 2019, the patient received the 1st dose of Engerix B adult. On 22nd April 2019, less than a day after receiving Engerix B adult, the patient experienced injection site pain and feeling hot. On an unknown date, the outcome of the injection site pain and feeling hot were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and feeling hot to be related to Engerix B adult.  Additional details were provided as follows:  The patient received Engerix B adult on the left arm. The patient reported that she experienced soreness at the injection site, and feels hot.  Also, the patient reported that she had a yeast allergy,  The patient did not know that there was yeast in the vaccine.  The patient planned to follow-up with her physician on an unknown date. The reporter gave consent to follow up.
LITTLE SORENESS IN ARM; This spontaneous report received from a patient via social media via a company representative concerned a 76 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the patient experienced little soreness in arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from little soreness in arm on MAR-2021. This report was non-serious.
unable to drink; teeth are hurting; fingers hurting; back hurting; every joint in body hurts; chills; fever; arm hurt all day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt all day), FEEDING DISORDER (unable to drink), TOOTHACHE (teeth are hurting), PAIN IN EXTREMITY (fingers hurting) and BACK PAIN (back hurting) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Medical history was not provided). Concomitant products included MELOXICAM (MOBIC), DULOXETINE, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for an unknown indication, CALCIUM.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm hurt all day). On 30-Mar-2021, the patient experienced FEEDING DISORDER (unable to drink), TOOTHACHE (teeth are hurting), PAIN IN EXTREMITY (fingers hurting), BACK PAIN (back hurting), ARTHRALGIA (every joint in body hurts), CHILLS (chills) and PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (arm hurt all day), FEEDING DISORDER (unable to drink), TOOTHACHE (teeth are hurting), PAIN IN EXTREMITY (fingers hurting), BACK PAIN (back hurting), ARTHRALGIA (every joint in body hurts), CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Breakthrough covid case. Pt presented to ER on 6/21/22 with c/o of right ear pain, nasal congestion, malaise. Hx of Pfizer vaccine x 3. DC home.
interment tingling/numbness in my arms & legs: primarily toes to knees & fingers to elbows, although not exclusively. It hasn?t been all limbs at the same time & is primarily my right hands, arms, feet, legs. This began several hours after shot and more frequent and pronounced over coming days. It comes and goes but to date (5/19) haven't had a day without this.  As a note, I had a similar reaction to the TDaP vaccine, and although the symptoms abated over time, it took months for them to completely go away.    Add?l side effects: extreme exhaustion like feeling drugged day of shot; this changed to very tired the following day and then to typical tiredness.  dry mouth/extremely thirsty day of shot & into next day (I had hydrated leading up to shot) vaccine site warm to touch for several days diarrhea on day 3 occasional nausea headache
left auxiliary Lymphadenopathy and lymphadenitis; left auxiliary Lymphadenopathy and lymphadenitis; eyelid swelling; left eye swelling; left eye swelling and tenderness; This is a spontaneous report from a contactable physician (patient). A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on the left arm, on 14Jan2021 07:30 at a single dose for COVID-19 immunization. Medical history included seizure, COVID prior to vaccination and penicillin allergy. Patient was not pregnant at the time of vaccination. Concomitant medication included levetiracetam (KEPPRA) and lacosamide (VIMPAT). No additional vaccines administered within 4 weeks before the vaccination. The patient previously took LAMICTAL and experienced allergy. The patient experienced Left auxiliary lympadenopathy and lymphadenitis, eyelid swelling, and left eye swelling and tenderness on 15Jan2021 15:00. Patient took BENADRYL as treatment for the events and was recovering. Patient had not been tested since the vaccination.  Information on the lot/batch number has been requested.
A full body rash on frontal plane of my body.   From instep to my neck.  It moves around to and from different areas.    It appears live hive bumps around my upper chest and neck.    Yesterday it started in my groin from naval to mid thigh.   Last night it was virulent on my upper chest and neck.  Today upon waking it was my ankle and wrist with moderate itching in left armpit.
little bit of fever but it only went up 1 degree; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75-year-old female patient received BNT162b2 (BNT162B2), on 27Sep2021 as dose 3 (booster), single (Lot number: 301308A) at the age of 74 years for covid-19 immunisation. The patient's relevant medical history included: "Type II diabetes" (unspecified if ongoing), notes: Type II diabetes diagnosed 7 years ago. Concomitant medication(s) included: METFORMIN taken for type 2 diabetes mellitus. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot: EN6201), administration date: 24Feb2021, when the patient was 74-year-old, for Covid-19 Immunization, reaction(s): "soreness to that area", "swelling in arm"; BNT162b2 (DOSE 2, SINGLE, Lot: EN6208), administration date: 16Mar2021, when the patient was 74-year-old, for Covid-19 Immunization, reaction(s): "soreness to that area", "swelling in arm". The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "little bit of fever but it only went up 1 degree". Relevant laboratory tests and procedures are available in the appropriate section.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201236628 same patient and product, different doses;US-PFIZER INC-202201236854 same patient and product, different doses;
Flublock to be administered to people 18 years old - 64 year old's. This client is 77, with no reported effects from vaccination. This client has given NO report of any adverse effect at this time.
Received 2nd shot of Vaccine after 7 weeks of 1st dose; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 25-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose). On 25-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications not provided Treatment information not provided; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Not Provided) with no associated AEs.
After the first vaccine, she developed warmth and lasted for weeks, but no temperature After the second vaccine, she developed taste aversion after 3 days, followed by headache for 3 days After the booster, she developed double vision 5 days later as documented in initial report
Information has been received from a consumer concerning a 12 month old male patient with "no known allergies" who on an unspecified dates was vaccinated with a first and second dose of ROTATEQ (dates, routes and lot numbers unspecified). It was reported that the baby patient began experiencing diarrhea and fever after each dose was given. The "Third dose was not given". The patient sought unspecified medical attention. At the time of the report the outcome of the patient was recovering. Additional information is not expected.
Information has been received from a medical assistant referring to unspecified patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ (lot # M019691, expiration date 02-NOV-2017) (dose and unit were unknown) orally. The vaccine was exposed to 47F for 15 minutes, 47F for 40 minutes, 47.3F for 40 minutes, 50F for 1 hour. No previous temperature excursion. Data logger was involved. No adverse effects reported. This is one of two reports received from the same source. Additional information has been requested.
PATIENT WIFE CALLED AND INFORMED PHARMACY PT DEVELOPPED SEIZURE AND DIFFICULTY BREATHING THE EVENING OF HIS FIRST COVID VACCINATION. PT IS NOW BETTER STAYED AT HOME
Started with injection site swelling and reddening, hot to touch, pulsating.  Onset of fever-reached to 101.9 F even with taking Tylenol as prescribed.  Headache-extremely severe.  Neck and spine pain extremely severe.  Entire body extreme pain.  High fever for about 36 hours.  72 hours after injection still running 99.6 degree with headache/body pain.
Sick for 2 days in bed after the shot...then the 3rd day...Headache... heart raising....dizziness..head feels weird...sick feeling...eyes blurry... no energy to do daily tasks...
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 24-JAN-2017, the patient received a dose of improperly stored ZOSTAVAX vial 19400 PFU; lot number M032360, expiration date 18-AUG-2017 (dose and route of administration were not provided) for prophylaxis. There was no adverse effect reported. No further information was provided. Administered dose of ZOSTAVAX was exposed to a temperature excursion of >5°F but <14°F for 10 minutes. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA012278: US-009507513-1702USA001825: US-009507513-1702USA001826: US-009507513-1702USA001827:
Pain at vaccine site with extensive redness and streaking. Pain started immediatley after vaccination. Redness started 24 hours post vaccine.
EXPIRED VACCINE USED; This spontaneous report received from a health care professional concerned a 29 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no illness at the time of vaccination. the patient had no past history of similar event. the patient had no adverse event after any previous vaccinations. the patient had no history of allergy to vaccine, drug or food. the patient had no pre-existing acute illness 30 days prior to vaccination. patient had no history of hospitalization in last 30 days, the patient had no family history of any disease (relevant to vaccination) or allergy. the patient was not pregnant at time of vaccination. the patient was not breastfeeding at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1805029 expiry: 25-MAY-2021) .5 ml, administered on 25-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAY-2021, the subject experienced expired vaccine used. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine used was not reported. This report was non-serious. This case, from the same reporter is linked to 20210549259.
tingling in arms, legs and torso. Hot flashes in face weak legs and sense of fogginess. Fast and irregular heartbeat.
This spontaneous report was received from a physician via field representative, refers to several patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were unspecified by the reporter. On an unknown dates, the patients were vaccinated with GARDASIL 9 injection, for prevention of HPV disease, (dose, frequency and route of administration not reported). Physician reported that several patients experienced adverse reaction to vaccinated with GARDASIL 9 therapy. Physician also stated that several patient experienced 'fainting' spells directly following vaccinated with GARDASIL 9 injection therapy. The outcome of the events was unknown. Causality assessment was not provided. Patient did not seek medical attention. No product quality complaint (PQC) was involved. No other adverse event information was given. Additional information has been requested.